Repositioning Drugs for a Better Outcome®
Nevakar is a specialty pharmaceutical company focused on developing innovative products in the injectable and ophthalmic spaces.
Our goal is to provide value to the healthcare system by offering enhanced and innovative products that are accessible and lead to better outcomes.
These drug repositioning efforts are focused on:
- Developing novel or superior formulations
- Designing improved and functional packaging
- Implementing effective regulatory and clinical strategies
The resulting new and repositioned products provide patient-centric benefits while ensuring an incremental value proposition for the healthcare system.
These new products with proprietary enhancements are filed with the FDA, primarily under the 505(b)(2) regulatory pathway.
Nevakar's business model is supported by state-of-the-art R&D infrastructure and a highly experienced management and leadership team.